Ai. Soder et al., AMPLIFICATION, INCREASED DOSAGE AND IN-SITU EXPRESSION OF THE TELOMERASE RNA GENE IN HUMAN CANCER, Oncogene, 14(9), 1997, pp. 1013-1021
Telomere length is maintained by the enzyme, telomerase, which has bee
n linked to cellular immortality and tumour progression, However, the
reasons for the high levels of telomerase found in human tumours are u
nknown, We have mapped the human telomerase RNA gene, (hTR), to chromo
some 3q26.3 and show the hTR gene to be amplified in four carcinomas,
(2/33 cervix, 1/31 head and neck, 1/9 lung), In addition, increased co
py numbers of the hTR locus was also observed in 97% of tumours, By in
situ hybridisation, the histological distribution of high levels of h
TR expression could be demonstrated in a lung tumour and its metastasi
s with hTR amplification, These results are the first report of geneti
c alterations involving a known component of telomerase in human cance
r, Indeed, it is also the first report of the amplification of a speci
fic locus within the chromosome 3q region frequently subject to copy n
umber gains in human tumours, In addition, we also show for the first
time the histological distribution of the RNA component of telomerase
in human tumours.